Publication Name	World Journal of Hepatology
Manuscript ID	14744
Country	United States

Received	2014-10-22 09:35
Peer-Review Started	2014-10-22 14:16
To Make the First Decision	2014-11-27 11:46
Return for Revision	2014-11-28 11:00
Revised	2014-12-13 07:00
Second Decision	2015-02-26 17:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-03-05 17:34
Articles in Press	2015-03-05 17:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-28 11:51
Publish the Manuscript Online	2015-05-20 16:43

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome
Manuscript Source	Invited Manuscript
All Author List	Adam S Bodzin and Ronald W Busuttil
Funding Agency and Grant Number
Corresponding Author	Ronald W Busuttil, MD, PhD, Distin­guished Professor and Executive Chairman, Department of Surgery, University of California, 757 Westwood Plaza, Suite 8236, Los Angeles, CA 90095, United States. rbusuttil@mednet.ucla.edu
Key Words	Hepatocellular carcinoma; Transplantation; Survival; Locoregional therapy; Resection
Core Tip	Hepatocellular carcinoma (HCC) is a growing malignancy with poor survival. New therapies for the hepatitis C virus may help prevent the development of this malignancy, however the growing obesity epidemic will continue to foster new cases of HCC. With the aid of advances in imaging patients might be diagnosed earlier making them candidates for curative resection or transplantation. In addition, with a growing population of patients undergoing surgery after being down-staged with locoregional therapy, we expect an improvement in long-term outcomes for HCC patients.
Publish Date	2015-05-20 16:43
Citation	Bodzin AS, Busuttil RW. Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome. World J Hepatol 2015; 7(9): 1157-1167
URL	http://www.wjgnet.com/1948-5182/full/v7/i9/1157.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i9.1157

Full Article (PDF)	WJH-7-1157.pdf
Full Article (Word)	WJH-7-1157.doc
Manuscript File	14744-Review.docx
Answering Reviewers	14744-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14744-Conflict-of-interest statement.pdf
Copyright License Agreement	14744-Copyright assignment.pdf
Peer-review Report	14744-Peer-review(s).pdf
Scientific Misconduct Check	14744-Scientific misconduct check.pdf
Scientific Editor Work List	14744-Scientific editor work list.pdf